| Active substance | roxadustat |
| Holder | Astellas Pharma B.V. |
| Status | closed |
| Indication | treatment of symptomatic anaemia of Chronic Kidney Disease in non-dialysis and dialysis patients, and where use of available treatment (IV iron or injectable ESAs) is not appropriate or is expected not to be appropriate, or patients who have a known contraindication for the currently available treatment or who do not tolerate the currently available treatment, or are expected not to tolerate this product |
| Public documents | |
| Laast update | 22/01/2024 |